This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

How to Invest During the 'Obamacare' Transition

NEW YORK (TheStreet) -- Which investments could and should prosper no matter what the outcome of the debate and potential revisions to the health care reform laws occur?

It's easy to get distracted. The U.S. is facing a government shutdown while politicians on both sides of the aisle use health care reform, aka "Obamacare," as a political hockey puck.

No doubt, there are many aspects of Obamacare that could merit reconsideration, and this may or may not happen. Meanwhile, investing decisions need to be made.

In developing an "Obamacare Transition" investment thesis, consider several key components.

Must Read: Three Top Investors: Bill Gates Must Go Too

First, any investment (this holds true at all times, in my view), must have a reasonable valuation. Second, the investment should have strong growth prospects. Third, the stock should be poised to benefit from the overall economic and demographic trends that are occurring. The latter is particularly important here as demographic trends are predictable and, most importantly, cannot be altered by political views or objectives.

It's only after an investment makes those three cuts that Obamacare should factor in.

Sectors To Avoid

In my opinion, most investors would be wise to avoid stocks in the following sectors -- large franchises, engineering and technology -- until there is more clarity in the law. Why? One of the provisions is that any employee working more than 30 hours would be considered full-time for purposes of qualifying under the law. Since most franchises own several stores and have over 50 employees, the costs could be harmful. This group would include Dunkin' Brands (DNKN - Get Report) and McDonald's (MCD - Get Report).

Franchise companies, such as Starbucks (SBUX - Get Report), that are growing aggressively on the international scale and earning an increasing share of their profits from overseas, could thrive -- at least on a relative basis.

Engineering and technology firms are on the avoid list because of their concentration of highly skilled, highly paid employees -- for instance, Oracle (ORCL) and Intel (INTC).

Sectors to Consider

Pharmacy companies and benefit management companies are likely to be two sectors that could profit. Pharmacy companies will likely benefit no matter how Obamacare plays out because of the demographic reality that we are all living longer and consuming pharmaceuticals to help us do so. Rite Aid (RAD - Get Report) and CVS Caremark (CVS - Get Report) could all be winners.

By the same reasoning, this would be a great gain for benefit managers such as Express Scripts (ESRX). The sector already handles over 50% of all prescriptions written and that figure is likely to increase in the coming years.

Ultimately, while it is easy to get emotional following the politically charged debates around Obamacare, as investors this also provides opportunities -- especially if there is a short-term pullback as a result of a government shutdown related to this argument.

At the time of publication the author had positions in all the stocks mentioned.

This article was written by an independent contributor, separate from TheStreet's regular news coverage.

Oliver Pursche is the president of GGFS, a boutique money management firm headquartered in Suffern, NY. Pursche is in charge of all business operations and serves on the firms' Investment Committee, Executive Committee and Board of Directors. Pursche is also a co-portfolio manager of the GMG Defensive Beta Fund (MPDAX).

Over the course of his career, Pursche has had the pleasure of working for venerable firms, such as PaineWebber and Neuberger Berman, as well as taking graduate courses at the University of Pennsylvania's Wharton School of Business. Most recently, Pursche published his first book, Immigrants: Unleashing the Economic Force at our Door.

Pursche is a trilingual financial services executive with more than 20 years of industry experience. His professional focus is on improving organizational structures and efficiencies, particularly in sales and the sales & marketing area. In the case of GGFS, Pursche helped four-fold AUM and five-fold revenues, as well as double profit margins from 2005 to 2013. Pursche accomplished this mainly through sales coaching, re-engineering the marketing processes and having an absolute focus on ROI.

Pursche is a frequent guest on CNBC, Fox Business News and Bloomberg Television. He also writes weekly columns for The Wall Street Journal Trading Deck,, Minyanville and The Street.

Pursche serves on the Advisory Board of the Cherie Blair Foundation, which focuses on helping women entrepreneurs around the world. He is a member of the New York City Ballet Serenade Society and a member of the Advisory Board at Gemini Fund Services.

Pursche lives in Fairfield, CT with his wife Virginia and their two dogs. For a more complete biography, visit Follow him on twitter @opursche

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CVS $102.00 0.00%
DNKN $42.05 0.00%
MCD $102.76 0.00%
RAD $6.28 0.00%
SBUX $60.07 0.00%


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs